AGT and cardiac hypertrophy: A previous study utilizing a systems biology approach investigating the sex differences in mice after angiotensin II‐induced hypertrophy found that inhibition of PPARα by a PPARα inhibitor blocked the sex differences in the development of cardiac hypertrophy (Harrington et al., 2017).